CA2630438A1 - Prodrugs of er.beta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds - Google Patents

Prodrugs of er.beta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds Download PDF

Info

Publication number
CA2630438A1
CA2630438A1 CA002630438A CA2630438A CA2630438A1 CA 2630438 A1 CA2630438 A1 CA 2630438A1 CA 002630438 A CA002630438 A CA 002630438A CA 2630438 A CA2630438 A CA 2630438A CA 2630438 A1 CA2630438 A1 CA 2630438A1
Authority
CA
Canada
Prior art keywords
beta
trien
estra
group
sulfamoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002630438A
Other languages
English (en)
French (fr)
Inventor
Olaf Peters
Gudrun Reddersen
Ralf Wyrwa
Alexander Hillisch
Walter Elger
Katja Prelle
Peter Droescher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Schering Pharma Aktiengesellschaft
Olaf Peters
Gudrun Reddersen
Ralf Wyrwa
Alexander Hillisch
Walter Elger
Katja Prelle
Peter Droescher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Aktiengesellschaft, Olaf Peters, Gudrun Reddersen, Ralf Wyrwa, Alexander Hillisch, Walter Elger, Katja Prelle, Peter Droescher filed Critical Bayer Schering Pharma Aktiengesellschaft
Publication of CA2630438A1 publication Critical patent/CA2630438A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002630438A 2005-11-29 2006-11-27 Prodrugs of er.beta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds Abandoned CA2630438A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005057225A DE102005057225A1 (de) 2005-11-29 2005-11-29 Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057225.1 2005-11-29
PCT/EP2006/011728 WO2007062876A1 (de) 2005-11-29 2006-11-27 Prodrugs er-beta-selektiver substanzen, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen

Publications (1)

Publication Number Publication Date
CA2630438A1 true CA2630438A1 (en) 2007-06-07

Family

ID=37909446

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002630438A Abandoned CA2630438A1 (en) 2005-11-29 2006-11-27 Prodrugs of er.beta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds

Country Status (14)

Country Link
EP (1) EP1957514A1 (de)
JP (1) JP2009517426A (de)
KR (1) KR20080072087A (de)
CN (1) CN101316856A (de)
AU (1) AU2006319382A1 (de)
BR (1) BRPI0619237A2 (de)
CA (1) CA2630438A1 (de)
CR (1) CR9997A (de)
DE (1) DE102005057225A1 (de)
EA (1) EA200801272A1 (de)
EC (1) ECSP088482A (de)
NO (1) NO20082918L (de)
WO (1) WO2007062876A1 (de)
ZA (1) ZA200805658B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3076964A1 (de) 2013-12-05 2016-10-12 Karo Pharma AB Östrogenrezeptor-betaagonisten zur behandlung von mesotheliom

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300335A2 (hu) * 2000-04-12 2003-07-28 Schering Ag. 8béta-hidrokarbil-szubsztituált ösztratriének mint szelektív hatású ösztrogének, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102004025966A1 (de) * 2004-05-21 2005-12-15 Schering Ag Estradiol-Prodrugs
US7534780B2 (en) * 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs

Also Published As

Publication number Publication date
ECSP088482A (es) 2008-06-30
ZA200805658B (en) 2010-01-27
CR9997A (de) 2008-09-22
DE102005057225A1 (de) 2007-05-31
EP1957514A1 (de) 2008-08-20
EA200801272A1 (ru) 2008-10-30
KR20080072087A (ko) 2008-08-05
BRPI0619237A2 (pt) 2011-09-20
NO20082918L (no) 2008-06-27
WO2007062876A1 (de) 2007-06-07
CN101316856A (zh) 2008-12-03
JP2009517426A (ja) 2009-04-30
AU2006319382A1 (en) 2007-06-07

Similar Documents

Publication Publication Date Title
US20070197488A1 (en) Prodrugs of ERbeta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds
US7534780B2 (en) Estradiol prodrugs
US5571933A (en) Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
RU2339643C2 (ru) 17 бета-оксиэстратриены
JP5795312B2 (ja) １７−ヒドロキシ−１７−ペンタフルオロエチル−エストラ−４，９（１０）−ジエン−１１−アリール誘導体、その製造方法、その誘導体を利用した諸疾患の治療
CA2768453A1 (en) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases
JP2009215317A (ja) ステロイドスルファメート、その製造方法、及びその使用
PT1272504E (pt) Estratrienos com uma substituição 8b-carbonilo como estrogénios com actividade selectiva
KR20150118153A (ko) 17.베타.-히드록시스테로이드 데히드로게나제 (akr1 c3)의 억제를 위한 에스트라-1,3,5(10),16-테트라엔-3-카르복스아미드
CA2564963A1 (en) Steroid prodrugs with androgenic effect
JP2007538025A (ja) エストラジオールプロドラッグ
US20070123500A1 (en) Prodrugs of ERbeta-selective substances, processes for their preparation and pharmaceutical compositions comprising these compounds
JP2007538027A (ja) エストリオール及びエステトロールプロドラッグ類
US7550451B2 (en) Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy
WO1998011124A1 (fr) Derives d'oestrariene a trisubstitution-d-homo-1,3,5,(10)
PL188079B1 (pl) Związek steroidowy o aktywności antykoncepcyjnej i przeciw osteoporozie, kompozycja farmaceutyczna,zastosowanie i sposób wytwarzania 16,17 anelowanych steroidów
JP2003513102A (ja) 選択的な作用を有するエストロゲンとしての１８−ノル−ステロイド
CA2630438A1 (en) Prodrugs of er.beta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds
US20050282793A1 (en) Steroid prodrugs with androgenic action
CA2629587A1 (en) Prodrug er.beta.-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds
EA008442B1 (ru) 9α-ЗАМЕЩЁННЫЕ ЭСТРАТРИЕНЫ В КАЧЕСТВЕ ЭСТРОГЕНОВ ИЗБИРАТЕЛЬНОГО ДЕЙСТВИЯ
UA79073C2 (en) 8- hydrocarbyl-substituted estratrienes for use as selective estrogens, pharmaceutical composition based thereon
MX2008006855A (en) Prodrugs of er-beta-selective substances method for production thereof and pharmaceutical compositions comprising the same
MX2008006856A (en) Prodrug erî²-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds
KR20070020454A (ko) 안드로겐 효과를 가지는 스테로이드 프로드러그

Legal Events

Date Code Title Description
FZDE Discontinued